TipRanks
Advertisement
Advertisement
Okunewitch Reiterates Buy on Emerging Nebokitug Data and Solid Cash Runway; Price Target Maintained at $5
PremiumRatingsOkunewitch Reiterates Buy on Emerging Nebokitug Data and Solid Cash Runway; Price Target Maintained at $5
5M ago
Chemomab Highlights New Nebokitug Data in PSC as Q1 2026 Update Underscores PSC–IBD Potential
Premium
Company Announcements
Chemomab Highlights New Nebokitug Data in PSC as Q1 2026 Update Underscores PSC–IBD Potential
5M ago
Chemomab Shareholders Approve Governance Resolutions and Capital Increase at May 5 Meeting
Premium
Company Announcements
Chemomab Shareholders Approve Governance Resolutions and Capital Increase at May 5 Meeting
5M ago
Chemomab Therapeutics reports FY25 EPS (1c) vs. (4c) last year
PremiumThe FlyChemomab Therapeutics reports FY25 EPS (1c) vs. (4c) last year
7M ago
Chemomab Therapeutics announces results of its Phase 2 SPRING trial
Premium
The Fly
Chemomab Therapeutics announces results of its Phase 2 SPRING trial
10M ago
Chemomab Therapeutics Advances PSC Treatment with Phase 3 Trial
Premium
Company Announcements
Chemomab Therapeutics Advances PSC Treatment with Phase 3 Trial
11M ago
Chemomab Therapeutics Advances Phase 3 Plans for Nebokitug
PremiumCompany AnnouncementsChemomab Therapeutics Advances Phase 3 Plans for Nebokitug
1y ago
Chemomab Therapeutics management to meet with Maxim
Premium
The Fly
Chemomab Therapeutics management to meet with Maxim
1y ago
Chemomab Therapeutics price target raised to $25 from $10 at Oppenheimer
Premium
The Fly
Chemomab Therapeutics price target raised to $25 from $10 at Oppenheimer
1y ago

Trending

Name
Price
Price Change
S&P 500
―
Dow Jones
―
Nasdaq 100
―